New algorithm could help GPs reduce antibiotic use in children with coughs and RTIs
Press release issued: 1 September 2016
Researchers have developed a technique that will help GPs identify which children with coughs and respiratory tract infections (RTIs) are most at risk of future hospitalisation.
They believe that, if this new algorithm is used to its full potential, it could reduce the amount of antibiotics prescribed to these children by as much as 10 per cent. The work is published in The Lancet Respiratory Medicine today.
Primary care practitioners such as GPs are responsible for 80 per cent of all antibiotic prescriptions in the UK. Around half of these are for RTIs, despite the fact that their effectiveness in treating RTIs has been shown to be limited.
Cough with respiratory tract infection (RTI) in children is the most common problem managed by GPs and primary care nurses in the NHS. GPs and nurses find making decisions about prescribing antibiotics in children with RTIs difficult. On the one hand, the over-prescription of antibiotics is recognised as a serious concern but on the other, they want ensure adequate treatment of a significant infection.
Led by researchers from the Centre for Academic Primary Care at the University of Bristol, the research team found seven characteristics that can be used to identify children with cough and RTI at very low, normal and high risk of future hospitalisation: short (≤3 days) illness; high temperature; age (<24 months); recession; wheeze; asthma; and vomiting giving the mnemonic ‘STARWAVe’.
If children have one or none, there is a very low risk of future hospitalisation; if three or more of these symptoms are present, there is a higher risk they will be hospitalised for their RTI in the following 30 days.
More than 8,390 children from 224 GP practices around the UK took part in the study. Among all the children in the cohort, there was a one per cent (or 1:100) risk of a child being hospitalised for their RTI in the following 30 days. If a child had none or just one of the characteristics, the risk of hospitalisation fell to 0.3 per cent (or 1:300). This then increased to 1.5 per cent (1:66) if the child had two to three symptoms, and quickly increased to 12 per cent (1:8) if the child had four or more.
Alastair Hay, a GP and Professor of Primary Care at the CAPC, led the research. He said: “We believe use of this algorithm could represent a step-change in the care of children with coughs and respiratory tract infections in primary care. We all know we need to curb the excessive use of antibiotics, but safely reducing prescribing means improving our identification of the patients who do and don’t need them.
“To our knowledge, this is the first time anyone has produced evidence that could be used to help hard-pushed, front-line clinicians make better antibiotic prescribing decisions.”
This research was carried out as part of the five-year ‘TARGET’ programme and included researchers from University of Southampton, Imperial College London, North Bristol NHS Trust, Public Health England and University of Washington, US. The programme, funded by the National Institute for Health Research Programme Grants for Applied Research Programme, was intended to give clinicians the tools they need to better care for these patients.
This work presents independent research funded by the National Institute for Health Research (NIHR) Programme Grants for Applied Research Programme (Grant Reference Number RP-PG-0608-10018).
‘Development and internal validation of a clinical rule to improve antibiotic use in children presenting to primary care to children with acute respiratory tract infection and cough: the ‘TARGET’ prognostic cohort study’ by Alastair Hay et al in The Lancet Respiratory Medicine.
The National Institute for Health Research (NIHR) is funded by the Department of Health to improve the health and wealth of the nation through research. The NIHR is the research arm of the NHS. Since its establishment in April 2006, the NIHR has transformed research in the NHS. It has increased the volume of applied health research for the benefit of patients and the public, driven faster translation of basic science discoveries into tangible benefits for patients and the economy, and developed and supported the people who conduct and contribute to applied health research. The NIHR plays a key role in the Government’s strategy for economic growth, attracting investment by the life-sciences industries through its world-class infrastructure for health research. Together, the NIHR people, programmes, centres of excellence, and systems represent the most integrated health research system in the world. For further information, visit the NIHR website.